First Patient Begins Sickle Cell Gene Therapy That F.D.A. Approved

A 12-year-old boy in the Washington, D.C., area faces months of procedures to remedy his disease. “I want to be cured,” he said.

View original article
Contributor: Gina Kolata and Kenny Holston